In the unprecedented absence of federal guidance, leading medical groups are issuing their own recommendations for who should ...
The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to ...
Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full dose with fewer side effects, according to a new study. The research is part of an ...
In a world of wild talk and fake news, help us stand up for the facts.
In a recent study published in The Lancet Regional Health Western Pacific, researchers compare the immunogenicity, reactogenicity, and safety of a half-dose Pfizer-BioNTech BNT162b2 coronavirus ...
In "COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients," moderator Jeff Goad, PharmD, MPH is joined by ...